GPT and diabetes mellitus: Further supporting an effect on β-cells with ALT, were experiments where pre-treatment of NOD recipients delayed diabetes development and lowered blood glucose concentrations over-time following adoptive transfer of G9C8 CD8 TCR transgenic cytotoxic lymphocytes.